Artículos por temáticas

Comorbidity Genes of Alzheimer's Disease and Type 2 Diabetes Associated with Memory and Cognitive Function

Cho SB.

Int J Mol Sci. 2024 Feb 12;25(4):2211. doi: 10.3390/ijms25042211.

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders

Carpi M, Mercuri NB, Liguori C.

Drugs. 2024 Nov;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3. Epub 2024 Oct 4.

Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alshammari MS, Alexiou A, Papadakis M, Bahaa MM, Batiha GE.

Neuropsychopharmacol Rep. 2024 Sep;44(3):639-649. doi: 10.1002/npr2.12445. Epub 2024 Jul 29.

Irisin in ischemic stroke, Alzheimer's disease and depression: a Narrative Review

Zhang QX, Zhang LJ, Zhao N, Yang L.

Brain Res. 2024 Dec 15;1845:149192. doi: 10.1016/j.brainres.2024.149192. Epub 2024 Aug 28.

Potential implications of polyphenolic compounds in neurodegenerative diseases

Shi R, Gao D, Stoika R, Liu K, Sik A, Jin M.

Crit Rev Food Sci Nutr. 2024;64(16):5491-5514. doi: 10.1080/10408398.2022.2155106. Epub 2022 Dec 16.

Association between treatment with sacubitril/valsartan and the risk of Alzheimer's disease: a clinical update

Garnier-Crussard A.

Alzheimers Res Ther. 2024 Aug 1;16(1):177. doi: 10.1186/s13195-024-01547-z.

Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?

Mamun AA, Shao C, Geng P, Wang S, Xiao J.

Int J Biol Sci. 2024 Jan 27;20(4):1332-1355. doi: 10.7150/ijbs.90982. eCollection 2024.

Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities

Zang WB, Wei HL, Zhang WW, Ma W, Li J, Yao Y.

Eur J Med Chem. 2024 Feb 5;265:116070. doi: 10.1016/j.ejmech.2023.116070. Epub 2023 Dec 18.

Inorganic polyphosphate: from basic research to diagnostic and therapeutic opportunities in ALS/FTD

Garcés P, Amaro A, Montecino M, van Zundert B.

Biochem Soc Trans. 2024 Feb 28;52(1):123-135. doi: 10.1042/BST20230257.

Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers

Bisi N, Pinzi L, Rastelli G, Tonali N.

Molecules. 2024 Feb 4;29(3):722. doi: 10.3390/molecules29030722.

Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases

Saleem A, Javed M, Akhtar MF, Sharif A, Akhtar B, Naveed M, Saleem U, Baig MMFA, Zubair HM, Bin Emran T, Saleem M, Ashraf GM.

Curr Gene Ther. 2024;24(2):122-134. doi: 10.2174/0115665232261931231006103234.

Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles

Liu X, Shen L, Wan M, Xie H, Wang Z.

J Nanobiotechnology. 2024 Apr 12;22(1):170. doi: 10.1186/s12951-024-02428-1.

Impact of NQO1 dysregulation in CNS disorders

Yuhan L, Khaleghi Ghadiri M, Gorji A.

J Transl Med. 2024 Jan 2;22(1):4. doi: 10.1186/s12967-023-04802-3.

The role and mechanism of dapagliflozin in Alzheimer disease: A review

Chen P, Liang L, Dai Y, Hui S.

Medicine (Baltimore). 2024 Sep 27;103(39):e39687. doi: 10.1097/MD.0000000000039687.

The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy

Shehjar F, Almarghalani DA, Mahajan R, Hasan SA, Shah ZA.

Cells. 2024 Jan 18;13(2):188. doi: 10.3390/cells13020188.